A Brighton Collaboration standardized template with key considerations for a benefit/risk assessment for the Medigen COVID-19 protein vaccine

por Estephan, Lila, Liu, Luke Tzu-Chi, Lien, Chia En, Smith, Emily R., Gurwith, Marc, Chen, Robert T.
Publicado 2023

An evaluation of the safety and immunogenicity of MVC-COV1901: Results of an interim analysis of a phase III, parallel group, randomized, double-blind, active-controlled immunobrid...

por Torales, Julio, Cuenca-Torres, Osmar, Barrios, Laurentino, Armoa-Garcia, Luis, Estigarribia, Gladys, Sanabria, Gabriela, Lin, Meei-Yun, Antonio Estrada, Josue, Estephan, Lila, Cheng, Hao-Yuan, Chen, Charles, Janssen, Robert, Lien, Chia-En
Publicado 2023

Safety and immunogenicity of homologous versus heterologous booster dose with AZD1222, mRNA-1273, or MVC-COV1901 SARS-CoV-2 vaccines in adults: An observer-blinded, multi-center, p...

por Estephan, Lila, Lin, Ying-Chin, Lin, Yi-Tsung, Chen, Yen-Hsu, Pan, Sung-Ching, Hsieh, Szu-Min, Torkehagen, Paal Fure, Weng, Yi-Jen, Cheng, Hao-Yuan, Estrada, Josue Antonio, Waits, Alexander, Chen, Charles, Lien, Chia En
Publicado 2023